Journal Home > Volume 15 , Issue 1
Nano Biomedicine and Engineering 2023, 15(1): 51-59 https://doi.org/10.26599/NBE.2023.9290007
Research Article | Open Access | Issue | Published: 26 April 2023

Labeling MCF-7 Cell Line with Interleukin-6/Calcium Phosphate Nanoparticles

Show Author's Information Seda Genç,  Nelisa Türkoğlu( )
Department of Molecular Biology and Genetics, Yıldız Technical University, Istanbul, Turkey
Keywords:
immunotherapy, interleukin (IL)-6, calcium phosphate nanoparticle, gene transfer
Cite this article:
Genç S, Türkoğlu N. Labeling MCF-7 Cell Line with Interleukin-6/Calcium Phosphate Nanoparticles. Nano Biomedicine and Engineering, 2023, 15(1): 51-59. https://doi.org/10.26599/NBE.2023.9290007
Download citation
EndNote(RIS)
BibTeX

1215

Views

94

Downloads

Citations

0

Crossref

N/A

WoS

0

Scopus

N/A

CSCD

Abstract Full text About this article

In recent years, nanoparticle systems have been frequently used as non-viral carriers for the treatment of genetically based diseases and cancer. However, the conjugate formation should be optimized by selecting a suitable carrier for the transport of each genetic material desired to be transported to the target cell. A suitable conjugate should be created by taking into account the size and zeta potential electrical characteristics of the cargo being transported. Nanocarrier systems can protect and package genetic material. Calcium phosphate nanoparticles (CaP NPs) with unique advantages have been a promising approach for in vitro and in vivo gene transfers. However, the biggest challenge of the CaP NPs is their unreducible size. In this study, CaP NPs were synthesized via the co-precipitation method using two stabilizing agents separately: magnesium nitrate and sodium citrate. The transfection efficiency of nanoparticles obtained by using sodium citrate in the MCF-7 cell line was observed to be more effective compared to magnesium nitrate-containing nanoparticles. The nanoparticles with a size of (248.1 ± 54) nm (polydispersity index (PDI), 0.3) and zeta potential of (–13.3 ± 2.8) mV were synthesized. The morphological properties of the particles were determined by scanning electron microscopy (SEM) and atomic force microscopy (AFM). Cytotoxicity of nanoparticles was performed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis using L929 mouse fibroblast cells. In the study, both CaP/plasmid DNA conjugation and naked plasmid DNA were transferred to MCF-7 cells, and the gene expression efficiency was determined by fluorescent microscopy via green fluorescent protein (GFP) expression. Gene expression efficiencies were determined as 24% (±1.7%) for naked pDNA and 76% (±2.3%) for CaP-conjugated pDNA, respectively.


menu
Abstract
Full text
Outline
About this article

Labeling MCF-7 Cell Line with Interleukin-6/Calcium Phosphate Nanoparticles

Show Author's information Seda Genç, Nelisa Türkoğlu( )
Department of Molecular Biology and Genetics, Yıldız Technical University, Istanbul, Turkey

Abstract

In recent years, nanoparticle systems have been frequently used as non-viral carriers for the treatment of genetically based diseases and cancer. However, the conjugate formation should be optimized by selecting a suitable carrier for the transport of each genetic material desired to be transported to the target cell. A suitable conjugate should be created by taking into account the size and zeta potential electrical characteristics of the cargo being transported. Nanocarrier systems can protect and package genetic material. Calcium phosphate nanoparticles (CaP NPs) with unique advantages have been a promising approach for in vitro and in vivo gene transfers. However, the biggest challenge of the CaP NPs is their unreducible size. In this study, CaP NPs were synthesized via the co-precipitation method using two stabilizing agents separately: magnesium nitrate and sodium citrate. The transfection efficiency of nanoparticles obtained by using sodium citrate in the MCF-7 cell line was observed to be more effective compared to magnesium nitrate-containing nanoparticles. The nanoparticles with a size of (248.1 ± 54) nm (polydispersity index (PDI), 0.3) and zeta potential of (–13.3 ± 2.8) mV were synthesized. The morphological properties of the particles were determined by scanning electron microscopy (SEM) and atomic force microscopy (AFM). Cytotoxicity of nanoparticles was performed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis using L929 mouse fibroblast cells. In the study, both CaP/plasmid DNA conjugation and naked plasmid DNA were transferred to MCF-7 cells, and the gene expression efficiency was determined by fluorescent microscopy via green fluorescent protein (GFP) expression. Gene expression efficiencies were determined as 24% (±1.7%) for naked pDNA and 76% (±2.3%) for CaP-conjugated pDNA, respectively.

Keywords: immunotherapy, interleukin (IL)-6, calcium phosphate nanoparticle, gene transfer

References(35)

[1]

K.F. Goliwas, J.S. Deshane, C.A. Elmets, et al. Moving immune therapy forward targeting TME. Physiological Reviews, 2021, 101(2): 417−425. https://doi.org/10.1152/physrev.00008.2020
DOI Google Scholar
[2]

C. Minichsdorfer, C. Wasinger, E. Sieczkowski, et al. Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cells. Melanoma Research, 2015, 25(4): 284−294. https://doi.org/10.1097/CMR.0000000000000172
DOI Google Scholar
[3]

W. Li, Y.H. Tian, Y. Liu, et al. Platycodin D exerts anti-tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis. The Journal of Toxicological Sciences, 2016, 41(3): 417−428. https://doi.org/10.2131/jts.41.417
DOI Google Scholar
[4]

T. Wirth, N. Parker, S. Ylä-Herttuala. History of gene therapy. Gene, 2013, 525(2): 162−169. https://doi.org/10.1016/j.gene.2013.03.137
DOI Google Scholar
[5]

H. Tian, J. Chen, X. Chen. Nanoparticles for gene delivery. Small, 2013, 9(12): 2034−2044. https://doi.org/10.1002/smll.201202485
DOI Google Scholar
[6]

R. Mohammadinejad, A. Dehshahri, V.S. Madamsetty, et al. In vivo gene delivery mediated by non-viral vectors for cancer therapy. Journal of Control. Release, 2020, 325: 249−275. https://doi.org/10.1016/j.jconrel.2020.06.038
DOI Google Scholar
[7]

N. Nayerossadat, T. Maedeh, P.A. Ali. Viral and nonviral delivery systems for gene delivery. Advanced Biomedical Research, 2012, 1: 27. https://doi.org/10.4103/2277-9175.98152
DOI Google Scholar
[8]

Y.K. Sung, S.W. Kim. Recent advances in the development of gene delivery systems. Biomaterials Research, 2019, 23: 8. https://doi.org/10.1186/s40824-019-0156-z
DOI Google Scholar
[9]

M. Ramamoorth, A. Narvekar. Non viral vectors in gene therapy- an overview. Journal of Clinical and Diagnostic Research, 2015, 9(1): GE01−GE06. https://doi.org/10.7860/JCDR/2015/10443.5394
DOI Google Scholar
[10]

T. Wang, J.R. Upponi, V.P. Torchilin. Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies. International Journal of Pharmaceutics, 2012, 427(1): 3−20. https://doi.org/10.1016/j.ijpharm.2011.07.013
DOI Google Scholar
[11]

I. Khan, K. Saeed, I. Khan. Nanoparticles: Properties , applications and toxicities. Arabian Journal of Chemistry, 2019, 12(7): 908−931. https://doi.org/10.1016/j.arabjc.2017.05.011
DOI Google Scholar
[12]
R.A. Saman, M. Iqbal. Nanotechnology-Based Drug Delivery Systems: Past , Present and Future. 2012: pp. 175–185.
[13]

T.J. Harris, J.J. Green, P.W. Fung, et al. Tissue-specific gene delivery via nanoparticle coating. Biomaterials, 2010, 31(5): 998−1006. https://doi.org/10.1016/j.biomaterials.2009.10.012
DOI Google Scholar
[14]

J. Zhao, G. Chen, X. Pang, et al. Calcium phosphate nanoneedle based gene delivery system for cancer genetic immunotherapy. Biomaterials, 2020, 250: 120072. https://doi.org/10.1016/j.biomaterials.2020.120072
DOI Google Scholar
[15]

J. Buck, P. Grossen, P.R. Cullis, et al. Lipid-based DNA therapeutics: Hallmarks of non-viral gene delivery. ACS Nano, 2019, 13(4): 3754−3782. https://doi.org/10.1021/acsnano.8b07858
DOI Google Scholar
[16]

F.L. Graham, A.J. van der Eb. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 1973, 52(2): 456−467. https://doi.org/10.1016/0042-6822(73)90341-3
DOI Google Scholar
[17]

V. Sokolova, O. Prymak, W. Meyer-Zaika, et al. Synthesis and characterization of DNA-functionalized calcium phosphate nanoparticles. Materwissenschaft und Werkstofftechnik, 2006, 37(6): 441−445. https://doi.org/10.1002/mawe.200600017
DOI Google Scholar
[18]

R. Khalifehzadeh, H. Arami. Biodegradable calcium phosphate nanoparticles for cancer therapy. Advances in Colloid and Interface Science, 2020, 279: 102157. https://doi.org/10.1016/j.cis.2020.102157
DOI Google Scholar
[19]

M.A. Khan, V.M. Wu, S. Ghosh. Gene delivery using calcium phosphate nanoparticles: Optimization of the transfection process and the effects of citrate and poly(l-lysine) as additives. Journal of Colloid and Interface Science, 2016, 471: 48−58. https://doi.org/10.1016/j.jcis.2016.03.007
DOI Google Scholar
[20]

E.V. Giger, J. Puigmartí-Luis, R. Schlatter. Gene delivery with bisphosphonate-stabilized calcium phosphate nanoparticles. Journal of Controlled Release, 2011, 150(1): 87−93. https://doi.org/10.1016/j.jconrel.2010.11.012
DOI Google Scholar
[21]

V.L. Truong-Le, S.M. Walsh, E. Schweibert, et al. Gene transfer by DNA-gelatin nanospheres. Archives of Biochemistry Biophysics, 1999, 361(1): 47−56. https://doi.org/10.1006/abbi.1998.0975
DOI Google Scholar
[22]

E.H. Chowdhury, T. Sasagawa, M. Nagaoka, et al. Transfecting mammalian cells by DNA/calcium phosphate precipitates: Effect of temperature and pH on precipitation. Analytical Biochemistry, 2003, 314(2): 316−318. https://doi.org/10.1016/S0003-2697(02)00648-6
DOI Google Scholar
[23]

E.H. Chowdhury, M. Kunou, M. Nagaoka, et al. High-efficiency gene delivery for expression in mammalian cells by nanoprecipitates of Ca-Mg phosphate. Gene, 2004, 341: 77−82. https://doi.org/10.1016/j.gene.2004.07.015
DOI Google Scholar
[24]

G. Mancardi, C.E. Hernandez Tamargo, D. Di Tommaso, et al. Detection of Posner’s clusters during calcium phosphate nucleation: A molecular dynamics study. Journal of Materials Chemistry B, 2017, 5(35): 7274−7284. https://doi.org/10.1039/c7tb01199g
DOI Google Scholar
[25]

M. Banik, T. Basu. Calcium phosphate nanoparticles: A study of their synthesis, characterization and mode of interaction with salmon testis DNA. Dalton Transactions, 2014, 43(8): 3244−3259. https://doi.org/10.1039/c3dt52522h
DOI Google Scholar
[26]

J. Li, Y.C. Chen, Y.C. Tseng, et al. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. Journal of Controlled Release, 2010, 142(3): 416−421. https://doi.org/10.1016/j.jconrel.2009.11.008
DOI Google Scholar
[27]

R. Khalifehzadeh, H. Arami. DNA-templated strontium-doped calcium phosphate nanoparticles for gene delivery in bone cells. ACS Biomaterials Science & Engineering, 2019, 5(7): 3201−3211. https://doi.org/10.1021/acsbiomaterials.8b01587
DOI Google Scholar
[28]

C.E. Pedraza, D.C. Bassett, M.D. McKee, et al. The importance of particle size and DNA condensation salt for calcium phosphate nanoparticle transfection. Biomaterials, 2008, 29(23): 3384−3392. https://doi.org/10.1016/j.biomaterials.2008.04.043
DOI Google Scholar
[29]

C. Wu, J. Xu, Y. Hao, et al. Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells. International Journal of Nanomedicine, 2017, 12: 7979−7992. https://doi.org/10.2147/IJN.S140957
DOI Google Scholar
[30]

T. Welzel, I. Radtke, W. Meyer-Zaika, et al. Transfection of cells with custom-made calcium phosphatenanoparticles coated with DNA. Journal of Materials Chemistry, 2004, 14(14): 2213−2217. https://doi.org/10.1039/B401644K
DOI Google Scholar
[31]

V.V. Sokolova, I. Radtke, R. Heumann, et al. Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles. Biomaterials, 2006, 27(16): 3147−3153. https://doi.org/10.1016/j.biomaterials.2005.12.030
DOI Google Scholar
[32]

C.M. Hoo, N. Starostin, P. West, et al. A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions. Journal of Nanoparticle Research, 2008, 10: 89−96. https://doi.org/10.1007/s11051-008-9435-7
DOI Google Scholar
[33]

Q.T.H. Shubhra, A. Oyane, H. Araki, et al. Calcium phosphate nanoparticles prepared from infusion fluids for stem cell transfection: Process optimization and cytotoxicity analysis. Biomaterials Science, 2017, 5(5): 972−981. https://doi.org/10.1039/c6bm00870d
DOI Google Scholar
[34]

B. Sun, M. Gillard, Y. Wu, et al. Bisphosphonate stabilized calcium phosphate nanoparticles for effective delivery of plasmid DNA to macrophages. ACS Applied Bio Materials, 2020, 3(2): 986−996. https://doi.org/10.1021/acsabm.9b00994
DOI Google Scholar
[35]

A. Peetsch, C. Greulich, D. Braun, et al. Silver-doped calcium phosphate nanoparticles: Synthesis, characterization, and toxic effects toward mammalian and prokaryotic cells. Colloids and Surfaces B,Biointerfaces, 2013, 102: 724−729. https://doi.org/10.1016/j.colsurfb.2012.09.040
DOI Google Scholar
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 01 April 2022
Revised: 23 February 2023
Accepted: 15 March 2023
Published: 26 April 2023
Issue date: March 2023

Copyright

© The Author(s) 2023.

Acknowledgements

This work was supported by Yıldız Technical University Scientific Research Project Coordinator (FYL-2020-3773).

Rights and permissions

This is an open-access article distributed under  the  terms  of  the  Creative  Commons  Attribution  4.0 International  License (CC BY) (http://creativecommons.org/licenses/by/4.0/), which  permits  unrestricted  use,  distribution,  and reproduction in any medium, provided the original author and source are credited.

Return